Fundraising FoxBioAmp Diagnostics
San Carlos, US · 3 known investors
Find your way into BioAmp Diagnostics
Sign up to see every warm intro you have to BioAmp Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioAmp Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections. The technology is intended to help physicians select the correct antibiotic and support efforts to combat antibiotic resistance.
Founders & leadership
Investors · 3
How we know: Berkeley Angel Network's portfolio page · Not right? Tell us
How we know: Blue Bear Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does BioAmp Diagnostics do?
- BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections. The technology is intended to help physicians select the correct antibiotic and support efforts to combat antibiotic resistance.
- Who are BioAmp Diagnostics's investors?
- BioAmp Diagnostics's investors include Berkeley Angel Network, Blue Bear Ventures, Illumina Accelerator.
- Where is BioAmp Diagnostics headquartered?
- BioAmp Diagnostics is headquartered in San Carlos, US.